Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Journal:

Nature Communications

Published:

2025-07-01

DOI:

10.1038/s41467-025-60990-0

Affiliations:

8

Authors:

11

Go to article

Institutions	Authors	Share
University of California, Davis (UC Davis), United States of America (USA)	7.750000	0.70
Carterra Inc., United States of America (USA)	1.000000	0.09
Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL), France	1.000000	0.09
Médicaments et Technologies pour la Santé (MTS), France	1.000000	0.09
UC Davis Comprehensive Cancer Center, United States of America (USA)	0.250000	0.02

Interested in Genetics?